Tecentriq – Display Banners Conference ASCO-GI – 55170

The 38-month follow-up data of the phase 3 OPERA trial showed that non-surgical treatment is...

A randomized trial investigating fucoidan in patients with locally advanced rectal cancer (LARC)...

Adding bevacizumab to atezolizumab plus cisplatin and gemcitabine did not significantly improve...

The combination therapy of botensilimab plus balstilimab resulted in encouraging anti-tumor...

The phase 3 SUNLIGHT trial demonstrated that bevacizumab plus trifluridine/tipiracil (FTD/TPI)...

The triplet regimen of nab-paclitaxel plus gemcitabine plus cisplatin (GCN) did not improve the...

The postoperative adjuvant combination therapy of sorafenib plus transarterial chemoembolization...

Patients with pre-treated, advanced biliary tract cancer (BTC) may benefit from treatment with...

The phase 3 NAPOLI-3 trial showed that liposomal irinotecan plus 5-fluorouracil/leucovorin and...

Zolbetuximab added to mFOLFOX6 improved the progression-free survival (PFS) and overall survival...

Single fraction radiation therapy (RT) outperformed best supportive care in reducing hepatic pain...